Check out our free and informative ezines and sign up now > Sun Pharma Sued Over Comtan Finnish drugmaker Orion has filed a patent infringement suit against Sun Pharma Global, which submitted an ANDA to market a generic version...
Karvy Stock Broking has rated Sun Pharmaceutical Industries as an outperformer with a target price of Rs 1245. Sun Pharma has stated that the USFDA has granted Osmotica\'s citizens petition regarding Venlafaxine extended...
MUMBAI, India, Nov. 27, 2008: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) announced that the USFDA has granted Osmotica’s Citizen Petition regarding venlafaxine extended...
Sun Pharmaceutical Industries had touched an intraday high of Rs 1,108.90 and an intraday low of Rs 1,051. At 2:51 pm, the share was quoting at Rs 1,072, down Rs 8.2, or 0.76%. Osmotica has piped Sun Pharma to get USFDA nod for...
Monday, December 01, 2008 (New Delhi) A reading showing fall in India's manufacturing output in the month just gone by, weak European markets and a further fall in US index futures pulled the domestic bourses lower in...
Tokyo: Honda Motor Co. increased global production in October to meet demand for small cars in the US and emerging markets. Output rose 1.4% to 368,245 vehicles last month, the company said in a statement .Expansion in China is...
At 10:06am (IST), Shares of Sun Pharma have gained by over 1.5% to Rs1093. Shares of Sun Pharma have gained by over 1.5% to Rs1093 after the company announced that its fully owned US subsidiary, Sun Pharmaceutical Industries,...
BANGALORE -(Dow Jones)- India's Sun Pharmaceutical Industries Ltd. (524715.BY) Thursday said the U.S. Food and Drug Administration has asked it to resubmit its application seeking approval to market the generic version of an...
MUMBAI, Nov 26 (Reuters) - Indian shares flip-flopped on Wednesday as investors used a firm start to unwind their positions ahead of the expiry of monthly derivatives on Thursday, but financial issues were higher on hopes for a...